Skip Navigation

BluesightⓇ’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion

Blog

BluesightⓇ’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion

Bluesight, the industry leader in Medication Intelligence™ solutions for hospitals, today announced the findings of…

Blog

Bluesight for Controlled Substances Named Category Leader in Best in KLAS 2020 Report

Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We …

Blog

Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report

KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering …

Blog

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …

Blog

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report

Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. …

1 of 1